{"name":"Bridge Biotherapeutics, Inc.","slug":"bridge-biotherapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"BBT-877","genericName":"BBT-877","slug":"bbt-877","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"BBT-877","genericName":"BBT-877","slug":"bbt-877","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxPUjc5LVJ4dnJkdWdPVElCNjY3SnBHWUV1WHI1akpCRE44WnFTN2k0ckFjeG52Y2lhQzN6bjByMXpOU3hHUjBfVkxFSUpjN2xZSXhiaExGR2JoYnJIUWFTSUZZelcxZEFqd0JmNW9uVWtvN1dWV19vcFk3Y3dKQ2JqODR1d0hwRHVPWHFiMTAxX1JDUGc1VWFnLUZWNA?oc=5","date":"2026-03-24","type":"pipeline","source":"openPR.com","summary":"EGFR Non Small Cell Lung Cancer Pipeline 2026: Key Companies, - openPR.com","headline":"EGFR Non Small Cell Lung Cancer Pipeline 2026: Key Companies,","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxQcTkxeXNwTXMxWFljZXNaY3BkNFhjLWZ6MFgtUEtEVm1zWU9UbHFtSGFEX0swQ0pUVS1xV29ULWNsdGdxUG5LNnV2N1I1MmZXSVdHUnNiVGMyN3ozZzBVcEFBQXpkeF9PWHJ3UUNBS21qdjZFcG44eW1GLU9RVnVUbFpVYndNWVZ3aEEzMXNwNFFjTHRoQnN1TW1xLTJORF8xT0p3X0QzSDd5RzVacUNvNG9aQVFsNFNYTmlhWFhLZ25rQQ?oc=5","date":"2026-03-06","type":"pipeline","source":"BioCentury","summary":"A pulmonary fibrosis proof-of-concept wave puts antifibrotic progress within reach - BioCentury","headline":"A pulmonary fibrosis proof-of-concept wave puts antifibrotic progress within reach","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxOZldualVTcmR3dTVxZFhWSnVwdXZfbjl2d2MzWklGYW5GWXJON3hWNVdINzNaVFllZHdjd3QyM1JyRTVnVEZ1NVNtMDRrcndsQ01TLWtnU1pkVXU0bjdJdjNOQU5tUlhfSmdxbmg0MXc1aHVlZ2Rsc1NtVGkxbTFEUzlvVE9XRDFscjJlN19jU2JNM0tzVnZxelNIdEVoUjFCUUhzdFdn?oc=5","date":"2026-01-12","type":"earnings","source":"BioWorld News","summary":"JPM 2026: Year kicks off with biopharma Q4 revenue and guidance - BioWorld News","headline":"JPM 2026: Year kicks off with biopharma Q4 revenue and guidance","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE9XeW4xZUVxVE9Xb2xoTkRjaEpKV0NBeVFyX0JOTEMxNzM5ZU5sekNwWUI2QkJINF8zY3hiMUlteHVYVFdhanJwX0NwOGtOMkFrVVhVNGVVX0NsSk5pa2JrRkdraTJFY084N2pCV0x30gFyQVVfeXFMUEluTFRuUF9fQXkxQXNDRDJEUlFMQXM5NlFDczJMRjN5RWh3SUJJUWk0R1FNQUF4RHd0NldzT2V3U0xDV0ZmM281SzBVRjdEc3B6TjhCdWJWdDZPekpRUE9JRlVjNXRlSDJkaGlUaWZWWHhR?oc=5","date":"2025-07-28","type":"pipeline","source":"koreabiomed.com","summary":"Bridge Bio to wind down new drug biz after acquisition by US investor Parataxsis - koreabiomed.com","headline":"Bridge Bio to wind down new drug biz after acquisition by US investor Parataxsis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxQaWVWMWtwb0hpcHFZSjBQc0xNY1FvSjJySHhpRjhXQmxjazFseXFiQVEzSDU2OWEycy1fUjRtYXhnN3NMal9XQldMSHo4N0tQWGU4dFlieVdfYnYzNmw5MEEzRWlMdHhwT0lIVVBvMjhFSWZHSVhPRUtuM2ZxTXJYVFB5QWlaRVlUb3U5MWd4aGRCMmZsSlZSTGJ3ckRKSUpOcmFUX01TNDA?oc=5","date":"2025-06-20","type":"pipeline","source":"Bitcoin Magazine","summary":"Parataxis Holdings To Create South Korea's First Bitcoin Treasury Company - Bitcoin Magazine","headline":"Parataxis Holdings To Create South Korea's First Bitcoin Treasury Company","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-02-28","type":"pipeline","source":"Business Wire","summary":"BridgeBio Oncology Therapeutics (BBOT) and Helix Acquisition Corp. II Announce Business Combination Agreement to Create Publicly Listed Biotechnology Company Advancing a Pipeline of RAS and PI3Kα-Targ","headline":"BridgeBio Oncology Therapeutics (BBOT) and Helix Acquisition Corp. II Announce Business Combination Agreement to Create ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxPQWRyT1JBR1hsMDRORXQxQnVkSVY4eElFVmFrSzliZFpKeUVubjhnSldHbHpMWkc5Wmo5VTh4c2Qyb3Q3TFp5dnkxeFVvZ2htRWo4c05fNWNDMDNSd3ZjZkZvTDQ4T2NyQUlCeTBuNjZrZGZ5Z19NcjJaTE9fY3dYMkl2aFN0Q2R3X2NJ?oc=5","date":"2025-02-28","type":"deal","source":"BioPharma Dive","summary":"BridgeBio oncology spinout to go public in blank-check merger - BioPharma Dive","headline":"BridgeBio oncology spinout to go public in blank-check merger","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgJBVV95cUxPODR6a0JUUjQ2d3pHa2c0M3gtN2ZRMDVGandaRFJha3VIMjg3OEdjWTRZTk1uMlV4Z3ktQUhXZGgxNW9oYmRPQ29NSlpwYklHenlyOElhTnhHTENKZldhZ1JiZ3RWU19CLW5vRUVGWEpneEs4dGY5V1gxRnhHanA2Ni1qQno5SnkyZG40dWxyYWVzVFM4Z2hKaHJqTlg2OEkzTnhMd0hveW5vdEhiRENMVEFxTlVtV1ZwejdjVHhnVlYtR1lhbDVuRzU3YlVETDR3bjhhZm40LWVNcUpKQVdpY2FHZl9JTWQ2VDVRR19KdjFVd1o5RUQzOERDMkZQcEpLWTNwZVJtcjgzR2ppYUJRS01kMnUxOUpLSDlwWFVHT19EaVZDSFhaS2F5cHpNa0MwZjcwVXY1X0dSejgwNUE?oc=5","date":"2025-01-28","type":"trial","source":"GlobeNewswire","summary":"Pulmonary Fibrosis Clinical Trial Pipeline Appears Robust - GlobeNewswire","headline":"Pulmonary Fibrosis Clinical Trial Pipeline Appears Robust","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxORHZKNlJ4Z3BwbUdQRUpuTkx3cW9KaW1wVnZoYmdfTkhHTjFhWndmck9Hcy1RcUVzcGJzSWphYkItcGE2NG1uSGpoeG0wakRlbFRJNEpQeGdwSDFDVEdiWnVLSkFLZWE5T3Roc2pLaWpwVDFnOTdkb2dKeWhhbFVDZzdaMlk2Y0dWTW9mNzZpSl9LVUtQS1gxdA?oc=5","date":"2024-05-02","type":"pipeline","source":"BioPharma Dive","summary":"BridgeBio spinout launches with $200M for KRAS cancer drugs - BioPharma Dive","headline":"BridgeBio spinout launches with $200M for KRAS cancer drugs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFBFM2ZBdVJCeEw3MUxtWUZqalBNa24yWXhHak9YMDY2YnktTDkyMTl6elpuRlAwOGQzSGJabC02bnJZckc1ZDB6Q1ZrWjZwQnZiZFlMYUhCbjVlTU9WU2hEbGdwTVdvZEZJazV0UzBB?oc=5","date":"2023-05-30","type":"pipeline","source":"KED Global","summary":"BIO USA 2023 to draw S.Korean biotech leaders, startups - KED Global","headline":"BIO USA 2023 to draw S.Korean biotech leaders, startups","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwJBVV95cUxQWHNuMmYyU0dYeFRna1RXMU02ck5fSklQZllyVFpBREZXNTRGOHJDejZGcGx4RzBFQzhXeDlpalAyOE8xWTlyTmZVUDAyZkhPV2xoNTZlRkRwOHBhUk14VnBOcEhQN3ZOaDdkb3lJZEdsaVRjWk9mS0tDRGU0VDRyQ0JYX0FlSHh5RjFaeWpab0hiNkwwZVk5NHhPNndOTGFPcWRpRjZJUllGVklqNEtZWnZGNVJidWJQbHA5SzYxRmJPT3JSdDZhZ0hKRjJFRmNUek9WUnU4R3NSOWt4bDhWTUI4RzB5WWYxXzRHa3RhbDU2a3UxY3RXYlBLbHNlLXU3bnNwazZEbS15MXFSdEVDaE5ZU0pfb0N2YXB0eWRTN0dQb3lzTTdaek5EMEFGaDVheng3ZFJkYw?oc=5","date":"2023-05-25","type":"trial","source":"PR Newswire","summary":"Idiopathic Pulmonary Fibrosis Clinical Trial Pipeline Appears Robust With 80+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - PR Newswire","headline":"Idiopathic Pulmonary Fibrosis Clinical Trial Pipeline Appears Robust With 80+ Key Pharma Companies Actively Working in t","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxNOWJ0eDRmR2lYZUNYTHotX0lRWk5ieGFQMjgwbmxnekd1dTMyVHVtOEk4UWs3eVk0RHB0ODU0bThaNnRrYzk0eTJpX3JEb3dGT3RlXzI0ZEhCMGVIekF5TDFEd0ZOdU1hQlM2MjJOcVQ4NzJKV2dtcEk2cDlFYTI3VkRiQ21mRTZRSnVNVk55eV91cEdkUmx3RGk4OW9xZWc?oc=5","date":"2019-07-18","type":"deal","source":"BioSpace","summary":"Boehringer Ingelheim Gambles $2.62 Billion on Two Fibrotic Disease Deals - BioSpace","headline":"Boehringer Ingelheim Gambles $2.62 Billion on Two Fibrotic Disease Deals","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}